Your browser doesn't support javascript.
loading
Anti-Amnesic Effects of Epigallocatechin Gallate on Scopolamine-Induced Learning and Memory Dysfunction in Sprague-Dawley Rats.
Kim, Min-Jeong; Hwang, Eun-Sang; Kim, Kwan Joong; Maeng, Sungho; Heo, Ho Jin; Park, Ji-Ho; Kim, Dae-Ok.
Affiliation
  • Kim MJ; Department of Food Science and Biotechnology, Kyung Hee University, Yongin 17104, Korea.
  • Hwang ES; Department of Gerontology, Graduate School of East-West Medical Science, Kyung Hee University, Yongin 17104, Korea.
  • Kim KJ; Department of Food Science and Biotechnology, Kyung Hee University, Yongin 17104, Korea.
  • Maeng S; Department of Comprehensive Health Science, Graduate School of East-West Medical Science, Kyung Hee University, Yongin 17104, Korea.
  • Heo HJ; Division of Applied Life Science (BK21), Institute of Agriculture and Life Science, Gyeongsang National University, Jinju 52828, Korea.
  • Park JH; Department of East-West Medicine, Graduate School of East-West Medical Science, Kyung Hee University, Yongin 17104, Korea.
  • Kim DO; Department of Food Science and Biotechnology, Kyung Hee University, Yongin 17104, Korea.
Antioxidants (Basel) ; 11(1)2021 Dec 21.
Article in En | MEDLINE | ID: mdl-35052505
ABSTRACT
Epigallocatechin gallate (EGCG) is a major flavan-3-ol of green tea polyphenols that exhibits various beneficial health effects, including antioxidant, anti-bacterial, and anti-inflammatory properties. This study aimed to evaluate whether EGCG prevents scopolamine-induced learning and memory impairment in in vivo and ex vivo models. Male Sprague-Dawley (SD) rats were pre-treated with EGCG (5 mg/kg/day; intraperitoneal injection (i.p.)) for 10 days. Then, EGCG and scopolamine (1 mg/kg/day; i.p.) were applied 60 and 30 min before the behavioral tests, respectively, for another 9 days. EGCG alleviated the cognitive deficits in the Y-maze, passive avoidance, and Morris water maze tests. EGCG showed improved cholinergic functions by decreasing acetylcholinesterase activity in hippocampi dissected from the brain of the rats after the behavioral tests. EGCG also reduced oxidative stress, partly due to increased superoxide dismutase activity and decreased malondialdehyde level in the hippocampi of the rat brains after the behavioral tests. Furthermore, EGCG attenuated the scopolamine-induced blockade of long-term potentiation in organotypic hippocampal tissue of seven-day-old SD rats. Taken together, these results suggested that EGCG is a potential therapeutic agent for alleviating cognitive dysfunction.
Key words